Peptide Association

Insights

NewsBlog
Start free intake

DisclosurePeptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.

The compound database

Peptide Database

264 therapeutic peptides with research summaries, clinical findings, and regulatory status. Every claim is cited.

FDA-approved
90
FDA-approved
Awaiting FDA
8
Awaiting FDA
No lawful pathway
166
No lawful pathway
1–13 of 13 · Oncology · FDA ApprovedClear filters
  1. 001

    Carfilzomib (Kyprolis)

    A tetrapeptide epoxyketone proteasome inhibitor that binds the proteasome irreversibly, with minimal off-target inhibition of other proteases in preclinical…

    Oncology · FDA Approved · Intravenous

    FDA-approved
  2. 002

    Bortezomib (Velcade)

    A dipeptidyl boronic acid that selectively and reversibly inhibits the 26S proteasome, disrupting the ubiquitin-proteasome pathway that degrades many…

    Oncology · FDA Approved · Subcutaneous injection, Intravenous

    FDA-approved
  3. 003

    Lutetium-177 dotatate (Lutathera)

    A radiolabeled somatostatin analog consisting of the peptide DOTA-Tyr3-octreotate chelated to the beta-emitting radioisotope lutetium-177. It binds…

    Oncology · FDA Approved · Intravenous

    FDA-approved
  4. 004

    Leuprolide (Lupron) - Oncology

    A GnRH agonist used in oncology for androgen deprivation therapy (ADT) in prostate cancer. Continuous administration downregulates pituitary GnRH receptors…

    Oncology · FDA Approved · Intramuscular injection (depot), Subcutaneous injection

    FDA-approved
  5. 005

    Degarelix (Firmagon)

    Degarelix is a synthetic decapeptide gonadotropin-releasing hormone (GnRH) receptor antagonist used for advanced prostate cancer, marketed as Firmagon. Unlike…

    Oncology · FDA Approved · Subcutaneous injection

    FDA-approved
  6. 006

    Triptorelin (Trelstar)

    Triptorelin is a synthetic decapeptide analogue of gonadotropin-releasing hormone (GnRH) that acts as a long-acting agonist. After an initial stimulatory…

    Oncology · FDA Approved · Intramuscular injection

    FDA-approved
  7. 007

    Histrelin (Vantas)

    Histrelin is a synthetic nonapeptide analogue of gonadotropin-releasing hormone (GnRH) that functions as a GnRH agonist. It is delivered by a subcutaneous…

    Oncology · FDA Approved · Subcutaneous implant

    FDA-approved
  8. 008

    Abarelix (Plenaxis)

    Abarelix is a synthetic decapeptide that functions as a gonadotropin-releasing hormone (GnRH) receptor antagonist. Because it blocks pituitary GnRH receptors…

    Oncology · FDA Approved · Intramuscular injection

    FDA-approved
  9. 009

    Elagolix (Orilissa)

    Elagolix is an orally administered small-molecule, non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist. While not a peptide itself, it blocks…

    Oncology · FDA Approved · Oral

    FDA-approved
  10. 010

    Relugolix (Orgovyx)

    Relugolix is an orally active non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist. Although it is not a peptide, it acts through the same…

    Oncology · FDA Approved · Oral

    FDA-approved
  11. 011

    177Lu-PSMA-617 (Pluvicto)

    177Lu-PSMA-617 (lutetium Lu 177 vipivotide tetraxetan) is a radioligand therapy that pairs a small urea-based peptidomimetic ligand for prostate-specific…

    Oncology · FDA Approved · Intravenous

    FDA-approved
  12. 012

    Tirbanibulin (Klisyri)

    Tirbanibulin is a synthetic small-molecule (non-peptide) inhibitor of tubulin polymerization and Src kinase signaling. It is applied topically as a 1% ointment…

    Oncology · FDA Approved · Topical

    FDA-approved
  13. 013

    Melphalan Flufenamide (Pepaxto)

    Melphalan flufenamide (melflufen, Pepaxto) is a first-in-class peptide-drug conjugate that links the alkylating agent melphalan to a dipeptide carrier. It…

    Oncology · FDA Approved · Intravenous

    FDA-approved

Index · all 264 peptides, A–Z

Important Medical Disclaimer

The information provided by the Peptide Association is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified, licensed healthcare provider before beginning any peptide therapy, supplement regimen, or making changes to an existing treatment plan.

Peptide therapies discussed on this site may not be FDA-approved for all listed indications. Individual results vary. The Peptide Association does not prescribe, diagnose, or treat any medical condition. Clinicians in our network are independently licensed practitioners; the Association checks each clinician’s NPI record but does not employ or directly supervise these clinicians.

© 2026 The Peptide Association. All rights reserved. Content on this site is protected under applicable intellectual property laws. The Peptide Association is not a medical practice.